Article

AUA 2007 Annual Meeting: Podcast - Day Two

Listen to the Urology Times Radio podcast from Day Two of the 2007 AUA Annual Meeting in Anaheim, California. This podcast includes interviews with highly regarded experts in urological medicine including: Anthony D'Amico, MD, discusses ADT and the associated risk of cardiac mortality Brent Yanke, MD, talks about endoscopic treatment of low-grade TCCJ. Stuart Wolf, MD, discusses the expansion and contraction of U.S. urologic practice

Related Videos
Medcast series
Elia Abou Charaweb, MD, answers a question during a video interview
Related Content
Published data show noninferior treatment-free survival with HIFU vs RP
December 12th 2024

Published data show noninferior treatment-free survival with HIFU vs RP

Hannah Clarke
Specifically, 90% of patients in the HIFU arm vs 86% of patients in the radical prostatectomy arm were free from subsequent definitive treatment at 30 months.
Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults
November 27th 2024

Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD
Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.
Sandip Prasad, MD, on UGN-102’s potential as a non-surgical option in NMIBC
December 10th 2024

Sandip Prasad, MD, on UGN-102’s potential as a non-surgical option in NMIBC

Sandip M. Prasad, MD, MPhil
"The durability response for these patients was impressive given the fact that these patients were those who, by definition and by inclusion criteria, were recurrent within a year at [baseline]," says Sandip M. Prasad, MD.
Former MLB player Dave Winfield shares lessons from baseball, philanthropy
November 15th 2024

Former MLB player Dave Winfield shares lessons from baseball, philanthropy

Urology Times staff
In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.
3d rendered illustration - bladder cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
December 9th 2024

High cystectomy-free survival seen with nadofaragene treatment in NMIBC

Benjamin P. Saylor
"Overall, the take-home message is that in patients with BCG-unresponsive non–muscle invasive bladder cancer, you can consider nadofaragene as an option among those that are available for treating these patients," said Vikram Narayan, MD.
FDA grants clearance to NanoKnife System for prostate tissue ablation
December 9th 2024

FDA grants clearance to NanoKnife System for prostate tissue ablation

Hannah Clarke
The clearance is supported by data from the PRESERVE trial, which evaluated the safety and effectiveness of the NanoKnife System in patients with intermediate-risk prostate cancer.
© 2024 MJH Life Sciences

All rights reserved.